Programme
Monday 10 May
08:55 to 09:00
Welcome
Mr Yazan Masannat, Ms Sarah Downey
09:40 to 10:00
NACT response rates in different tumour types
Speaker To Be Confirmed
10:00 to 10:20
ATNEC – de-escalating axillary treatment after NACT
Professor Amit Goyal
10:20 to 10:40
Planning your breast surgery around systemic therapy
TBC
10:40 to 10:55
Q&A panel discussion with speakers
All Faculty
09:55 to 10:10
Patient experience 1
TBC
10:10 to 10:25
Patient experience 2
TBC
10:25 to 10:55
Breast-conserving surgery versus mastectomy in BRCA mutation carriers: A systematic review and meta-analysis of oncological outcomes
TBC
11:35 to 11:55
Liver metastases and selecting patients for local treatment (lap liver resection series)
TBC
11:55 to 12:05
Local breast progression with otherwise stable metastatic disease – a surgical approach
TBC
12:05 to 12:25
Radiation oncology
TBC
12:25 to 12:50
Q&A panel discussion with speakers (1)
All Faculty
11:35 to 11:50
POSH study – 20-year follow-up
Professor Ramsey Cutress
11:50 to 12:05
Pregnancy associated breast cancer: National data & outcomes
Mr Ashu Gandhi
12:05 to 12:20
Managing endocrine side effects in menopause
Dr Charlotte Gooding
12:20 to 12:35
Are the rates of early onset breast cancer rising
Associate Professor Toral Gathani
12:35 to 12:50
Q&A panel discussion with speakers
All Faculty
11:35 to 11:50
AI in Breast Imaging
TBC
11:50 to 12:05
AI in breast surgery
Speaker To Be Confirmed
12:05 to 12:20
Impact of AI on surgical research
Professor Aoife Lowery
12:20 to 14:35
Endoscopic Nipple Sparing Mastectomy
Speaker To Be Confirmed
12:35 to 12:50
Q&A panel discussion with speakers
All Faculty
14:05 to 14:35
Improving outcomes of implant-based reconstruction
TBC
14:25 to 14:45
When to make the switch from implant to autologous reconstruction
TBC
14:45 to 15:05
Latest advances in lymphedema surgery
TBC
14:05 to 14:20
Delivering breast care to a rural population
Mr Ilyas Khattak
14:20 to 14:35
Managing capacity in SACT assessment clinics. A multi tumour site, multi-disciplinary, Independent Prescriber led virtual clinic
Speaker To Be Confirmed
14:45 to 16:05
AI systems giving prognostic & predictive information
Speaker To Be Confirmed
16:00 to 16:30
Breast Care in China
TBC
16:40 to 17:00
International perspective - No woman left behind: local leadership in delivering change
Speaker To Be Confirmed
17:00 to 17:20
Diaspora networks and sustainable partnerships
Speaker To Be Confirmed
17:20 to 17:40
Results from the AVOID audit and imaging management of the axilla
Speaker To Be Confirmed
17:40 to 17:55
Q&A panel discussion with speakers
All Faculty
16:40 to 16:55
GLP-1 agonists and surgery: Perioperative and postoperative risks and outcomes,
TBC
16:55 to 17:05
Symptomatic presentations in patients on GLP-1 therapy
TBC
17:05 to 17:20
GLP-1, weight loss and breast cancer incidents
TBC
17:20 to 17:35
Every episode of care counts – lifestyle & prevention where does GLP-1 fit?
Miss Jennifer Rusby
17:40 to 17:55
Q&A panel discussion
All Faculty
Tuesday 11 May
08:30 to 08:40
Single-port endoscopic nipple – sparing mastectomy with the HandXTM hand-held articulating system
Dr Vasileios Kalles
08:40 to 08:50
Hidden scar nipple sparing mastectomy and direct to implant reconstruction - Video with assessment of complications, oncological outcomes and aesthetic outcome
Mr John Mathew
09:00 to 09:15
Two stage reconstruction
Dr Antonio Tejerina
09:15 to 09:30
Polyurethane implants do we need ADMs at all
Professor Alberto Rancati
09:30 to 09:40
What surgeons need to know about ALCL
Mr Jamie Vatish
09:40 to 09:50
Setting up an ALCL MDT
Mr Aadil Khan
09:50 to 10:15
Q&A panel discussion with speakers
All Faculty
09:00 to 09:15
Lifestyle measures
Professor Marjolein Smidt
09:15 to 09:30
Importance of exercise
Professor John Saxton
09:30 to 09:45
APPROACH: An app plus behavioural support to promote physical activity as part of cancer care
Professor Abigail Fisher
09:45 to 09:55
Cando3 – trial update
Dr Robert Kemp
09:00 to 09:15
Oncoplastic fellowships in the UK
Professor Lynda Wyld
09:15 to 09:30
Trainees in research (MFAC)
Ms Anna Isaac, Mr Gareth Irwin
11:10 to 11:30
Collaborative European research
Professor Jana de Boniface, Professor Marjolein Smidt
13:00 to 13:20
How to write a business case (and be successful)
Professor Christopher Holcombe
11:30 to 11:45
Oncology and treatment side effects
Dr Suzy Cleator
11:45 to 12:00
Surgery: Is conservation an option
Mr Ross McLean
12:30 to 12:45
Q&A panel discussion with speakers
All Faculty
11:30 to 11:45
Understanding resistance in triple negative breast cancer
Dr Stephen Sammut
11:45 to 12:00
New therapeutic approaches for ER+ HER2- Breast cancer (CDK4/5, oral new oral SERDs, ESR1 testing)
Dr Olga Oikonomidou
12:00 to 12:15
HER2 positive disease update
Professor Iain Macpherson
12:15 to 12:30
Do all ER positive, HER2 positive need chemotherapy
Professor Carlo Palmieri
13:30 to 13:50
Video technical skills
Professor Alberto Rancati, Dr Antonio Tejerina
14:05 to 14:35
Cancer: Why me?
Miss Leena Chagla
Pharmaceutical companies have solely provided sponsorship for the ABS Conference 2027 through the purchase of exhibition space and/ or sponsored symposia and have had no further input into the arrangements or programme for the event. Sessions delivered with input from sponsors will always be marked on the programme. View the list of sponsors here